N/A
N=120
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
Congestive Heart Failure · Chronic Obstructive Pulmonary Disease · Cirrhosis · Colon Carcinoma · Lung Cancer
Bottom Line
View on ClinicalTrials.gov: NCT00122135 ↗Enrolled (actual)
120
Serious AEs
0.0%
Results posted
Nov 2015
Primary outcome: Primary: Presence of Discussions About End of Life Care Goals/Wishes — 13; 8 participants — p=.77
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Values Inventory (VI) (Other)
- Age
- Adult, Older Adult · 55+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Sep 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Presence of Discussions About End of Life Care Goals/Wishes |
13; 8 | .77 |
Summary
The goal of this research agenda is to improve the quality of end-of-life care by explicitly identifying values that will guide the decision-making process, with a particular emphasis on the role of ethnic, racial and cultural factors.
Eligibility Criteria
Inclusion Criteria
- Eligible patients will be at risk for 6-12 month mortality and have one of the following diagnoses:
- congestive heart failure, with ejection fraction of <25%;
- severe chronic obstructive pulmonary disease/emphysema with dependence on oxygen;
- chronic liver disease with cirrhosis and ascites;
- colon carcinoma with liver metastases; or
- non-small cell cancer of the lung, stage III or IV
- chronic kidney disease on renal replacement therapy, with previous hospitalization
- All participants will be age 55 years or older and will be recruited through the clinics at the Houston VAMC.
Exclusion Criteria
- Patients with dementia
- Patients less than 55 years old
Data sourced from ClinicalTrials.gov (NCT00122135). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.